Current Good Manufacturing Practices for Blood and Blood Components: Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection; Correction of Effective Date
other · Food and Drug Administration · Rule · Published 1996-12-19 · Effective 1996-09-09 · 61 FR 66919
Document
Document number
96-32271
Federal Register citation
61 FR 66919
CFR reference
21 CFR 606
Type
Rule
Action
Final rule; correction of effective date.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1996-12-19
Effective date
1996-09-09
HHS docket
Docket No. 91N-0152
Abstract
The Food and Drug Administration (FDA) is correcting a final rule on current good manufacturing practices for blood and blood components, that appeared in the Federal Register of September 9, 1996 (61 FR 47413). The document was published with an incorrect effective date. The effective date had been inadvertently switched with the comment deadline for the information collection requirements. This document corrects those errors.